These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 28775928)

  • 61. Outcomes and Treatment Algorithm in Glioblastoma Patients 80 Years and Older.
    Fogg D; Gersey ZC; Pease M; Mallela AN; Andrews E; Plute T; Pearce TM; Njoku-Austin C; Anthony A; Amankulor NM; Zinn P
    World Neurosurg; 2023 Oct; 178():e540-e548. PubMed ID: 37516146
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The efficacy and safety of extended adjuvant temozolomide following concurrent radio-chemotherapy among Egyptian patients with newly diagnosed glioblastoma multiforme.
    Attia AM; Eltybe HA; Sedik MF; Hefni AM; Abdelgawad MI; Farrag A; Essa AA; El-Barody MM; Attia NM
    Am J Cancer Res; 2022; 12(1):355-370. PubMed ID: 35141023
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Comparative efficacy and safety of therapeutics for elderly glioblastoma patients: A Bayesian network analysis.
    Zhao B; Wu J; Xia Y; Li H; Wang Y; Qu T; Xing H; Wang Y; Ma W
    Pharmacol Res; 2022 Aug; 182():106316. PubMed ID: 35724820
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Presentation, management, and outcome of newly diagnosed glioblastoma in elderly patients.
    Tanaka S; Meyer FB; Buckner JC; Uhm JH; Yan ES; Parney IF
    J Neurosurg; 2013 Apr; 118(4):786-98. PubMed ID: 23176331
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Trans sodium crocetinate with temozolomide and radiation therapy for glioblastoma multiforme.
    Gainer JL; Sheehan JP; Larner JM; Jones DR
    J Neurosurg; 2017 Feb; 126(2):460-466. PubMed ID: 27177177
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The efficacy of hypofractionated radiotherapy (HFRT) with concurrent and adjuvant temozolomide in newly diagnosed glioblastoma: A meta-analysis.
    Guo L; Li X; Chen Y; Liu R; Ren C; Du S
    Cancer Radiother; 2021 Apr; 25(2):182-190. PubMed ID: 33436285
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Phase 2 Study of Bortezomib Combined With Temozolomide and Regional Radiation Therapy for Upfront Treatment of Patients With Newly Diagnosed Glioblastoma Multiforme: Safety and Efficacy Assessment.
    Kong XT; Nguyen NT; Choi YJ; Zhang G; Nguyen HN; Filka E; Green S; Yong WH; Liau LM; Green RM; Kaprealian T; Pope WB; Nghiemphu PL; Cloughesy T; Lassman A; Lai A
    Int J Radiat Oncol Biol Phys; 2018 Apr; 100(5):1195-1203. PubMed ID: 29722661
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Second-line chemotherapy with fotemustine in temozolomide-pretreated patients with relapsing glioblastoma: a single institution experience.
    Scoccianti S; Detti B; Sardaro A; Iannalfi A; Meattini I; Leonulli BG; Borghesi S; Martinelli F; Bordi L; Ammannati F; Biti G
    Anticancer Drugs; 2008 Jul; 19(6):613-20. PubMed ID: 18525321
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Retrospective comparison of standard and escalated doses of radiotherapy in newly diagnosed glioblastoma patients treated with concurrent and adjuvant temozolomide.
    Guler OC; Yıldırım BA; Önal C; Topkan E
    Indian J Cancer; 2019; 56(1):59-64. PubMed ID: 30950447
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A pilot study of glioblastoma multiforme in elderly patients: treatments, O-6-methylguanine-DNA methyltransferase (MGMT) methylation status and survival.
    Abhinav K; Aquilina K; Gbejuade H; La M; Hopkins K; Iyer V
    Clin Neurol Neurosurg; 2013 Aug; 115(8):1375-8. PubMed ID: 23333005
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Postoperative treatment of primary glioblastoma multiforme with radiation and concomitant temozolomide in elderly patients.
    Combs SE; Wagner J; Bischof M; Welzel T; Wagner F; Debus J; Schulz-Ertner D
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):987-92. PubMed ID: 17967509
    [TBL] [Abstract][Full Text] [Related]  

  • 72. MGMT inactivation and clinical response in newly diagnosed GBM patients treated with Gliadel.
    Grossman R; Burger P; Soudry E; Tyler B; Chaichana KL; Weingart J; Olivi A; Gallia GL; Sidransky D; Quiñones-Hinojosa A; Ye X; Brem H
    J Clin Neurosci; 2015 Dec; 22(12):1938-42. PubMed ID: 26249244
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Hypofractionated radiation therapy with temozolomide versus standard chemoradiation in patients with glioblastoma multiforme (GBM): A prospective, single institution experience.
    Rayan A; Abdel-Kareem S; Hasan H; Zahran AM; Gamal DA
    Rep Pract Oncol Radiother; 2020; 25(6):890-898. PubMed ID: 32982596
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Prognostic implications of the subcellular localization of survivin in glioblastomas treated with radiotherapy plus concomitant and adjuvant temozolomide.
    Saito T; Sugiyama K; Takeshima Y; Amatya VJ; Yamasaki F; Takayasu T; Nosaka R; Muragaki Y; Kawamata T; Kurisu K
    J Neurosurg; 2018 Mar; 128(3):679-684. PubMed ID: 28430038
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Extended adjuvant temozolomide in newly diagnosed glioblastoma: A single-center retrospective study.
    Chen J; Wang T; Liu W; Qiu H; Zhang N; Chen X; Ding X; Zhang L
    Front Oncol; 2022; 12():1000501. PubMed ID: 36483042
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Prognostic significance of O6-methylguanine-DNA methyltransferase protein expression in patients with recurrent glioblastoma treated with temozolomide.
    Nagane M; Kobayashi K; Ohnishi A; Shimizu S; Shiokawa Y
    Jpn J Clin Oncol; 2007 Dec; 37(12):897-906. PubMed ID: 18156172
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Toxicity and survival in primary glioblastoma patients treated with concomitant plus adjuvant temozolomide versus adjuvant temozolomide: results of a single-institution, retrospective, matched-pair analysis.
    Gutenberg A; Bock HC; Reifenberger G; Brück W; Giese A
    Acta Neurochir (Wien); 2013 Mar; 155(3):429-35. PubMed ID: 23254891
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Survival impact of delaying postoperative chemoradiotherapy in newly-diagnosed glioblastoma patients.
    Zhang M; Xu F; Ni W; Qi W; Cao W; Xu C; Chen J; Gao Y
    Transl Cancer Res; 2020 Sep; 9(9):5450-5458. PubMed ID: 35117910
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Glioblastoma Treatment in the Elderly.
    Okada M; Miyake K; Tamiya T
    Neurol Med Chir (Tokyo); 2017 Dec; 57(12):667-676. PubMed ID: 29081442
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Temozolomide in radio-chemotherapy combined treatment for newly-diagnosed glioblastoma multiforme: phase II clinical trial.
    Lanzetta G; Campanella C; Rozzi A; Nappa M; Costa A; Fedele F; Innocenzi G; Gagliardi FM; Salvati M; Minniti G; Frati A; Frati L; Vecchione A
    Anticancer Res; 2003; 23(6D):5159-64. PubMed ID: 14981983
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.